U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07034677) titled 'Treatment With Indapamide in Patients With Post-Surgical Hypoparathyroidism' on June 15.
Brief Summary: The aim of this study is to investigate the effect of daily treatment with Indapamide for 14 days on urinary calcium excretion in patients with post surgical hypoparathyroidisme.
Study Start Date: June, 2025
Study Type: INTERVENTIONAL
Condition:
Hypoparathyroidism Post-surgical
Intervention:
DRUG: Indapamide 1.5 MG SR
14 days treatment with indapamide 1.5 mg/day compared to placebo
DRUG: Placebo
14 days treatment with placebo
Recruitment Status: RECRUITING
Sponsor: Lars Rejnmark
Information provided by (Responsible Par...